Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Effect of Moderate Exercise on Serum Interferon-Gamma and Interleukin-17 Levels in the Morphine Withdrawal Period.

Heidarianpour A, Vahidian Rezazadeh M, Zamani A.

Int J High Risk Behav Addict. 2016 Feb 13;5(2):e26907. doi: 10.5812/ijhrba.26907.

2.

Coping with Multiple Sclerosis Scale: Reconsideration of the Factorial Structure.

Parkerson HA, Kehler MD, Sharpe D, Hadjistavropoulos HD.

Int J MS Care. 2016 Jul-Aug;18(4):192-200. doi: 10.7224/1537-2073.2015-031.

3.

How Do People with Multiple Sclerosis Experience Prognostic Uncertainty and Prognosis Communication? A Qualitative Study.

Dennison L, McCloy Smith E, Bradbury K, Galea I.

PLoS One. 2016 Jul 19;11(7):e0158982. doi: 10.1371/journal.pone.0158982.

4.

Rumination and behavioural factors in Parkinson's disease depression.

Julien CL, Rimes KA, Brown RG.

J Psychosom Res. 2016 Mar;82:48-53. doi: 10.1016/j.jpsychores.2016.01.008.

5.

The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective.

Messina MJ, Dalla Costa G, Rodegher M, Moiola L, Colombo B, Comi G, Martinelli V.

Mult Scler Int. 2015;2015:353828. doi: 10.1155/2015/353828.

6.

Psychological well-being in people with multiple sclerosis in an Iranian population.

Dehnavi SR, Heidarian F, Ashtari F, Shaygannejad V.

J Res Med Sci. 2015 Jun;20(6):535-9. doi: 10.4103/1735-1995.165942.

7.

Prevalence and risk factors for depression in women with multiple sclerosis: a study from Iran.

Mohammadi K, Rahnama P, Montazeri A.

Ann Gen Psychiatry. 2015 Sep 22;14:29. doi: 10.1186/s12991-015-0069-8.

8.
9.

The relationship of age, function, and psychological distress in multiple sclerosis.

Jones SM, Amtmann D.

Psychol Health Med. 2015;20(6):629-34. doi: 10.1080/13548506.2014.979209.

10.

Health care worry is associated with worse outcomes in multiple sclerosis.

Jones SM, Amtmann D.

Rehabil Psychol. 2014 Aug;59(3):354-9. doi: 10.1037/a0037074.

11.

Change in the Health-Related Quality of Life of Multiple Sclerosis Patients over 5 Years.

Janzen W, Turpin KV, Warren SA, Marrie RA, Warren KG.

Int J MS Care. 2013 Spring;15(1):46-53. doi: 10.7224/1537-2073.2012-020.

12.

Effectiveness of a relationship enrichment program for couples living with multiple sclerosis.

Tompkins SA, Roeder JA, Thomas JJ, Koch KK.

Int J MS Care. 2013 Spring;15(1):27-34. doi: 10.7224/1537-2073.2012-002.

13.

Mindfulness based interventions in multiple sclerosis--a systematic review.

Simpson R, Booth J, Lawrence M, Byrne S, Mair F, Mercer S.

BMC Neurol. 2014 Jan 17;14:15. doi: 10.1186/1471-2377-14-15. Review.

14.

Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis.

Hind D, Cotter J, Thake A, Bradburn M, Cooper C, Isaac C, House A.

BMC Psychiatry. 2014 Jan 9;14:5. doi: 10.1186/1471-244X-14-5. Review.

15.

Validation of interpersonal support evaluation list-12 (ISEL-12) scores among English- and Spanish-speaking Hispanics/Latinos from the HCHS/SOL Sociocultural Ancillary Study.

Merz EL, Roesch SC, Malcarne VL, Penedo FJ, Llabre MM, Weitzman OB, Navas-Nacher EL, Perreira KM, Gonzalez F, Ponguta LA, Johnson TP, Gallo LC.

Psychol Assess. 2014 Jun;26(2):384-94. doi: 10.1037/a0035248.

17.

Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.

Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, Villoslada P, Malikova I, Roger E, Kinkel RP, McDonald J, Bacchetti P, Waubant E.

PLoS One. 2013 Oct 9;8(10):e75416. doi: 10.1371/journal.pone.0075416.

18.

Social support associated with quality of life in home care patients with intractable neurological disease in Japan.

Nishida T, Ando E, Sakakibara H.

Nurs Res Pract. 2012;2012:402032. doi: 10.1155/2012/402032.

19.

Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis.

Hadgkiss EJ, Jelinek GA, Weiland TJ, Rumbold G, Mackinlay CA, Gutbrod S, Gawler I.

Neurol Sci. 2013 Feb;34(2):187-95. doi: 10.1007/s10072-012-0982-4.

20.

Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.

de Sa JC, Airas L, Bartholome E, Grigoriadis N, Mattle H, Oreja-Guevara C, O'Riordan J, Sellebjerg F, Stankoff B, Vass K, Walczak A, Wiendl H, Kieseier BC.

Ther Adv Neurol Disord. 2011 May;4(3):139-68. doi: 10.1177/1756285611403646.

Supplemental Content

Support Center